Results 261 to 270 of about 61,873 (295)

Long-term efficacy and tolerability of bilateral pallidal stimulation to treat tardive dyskinesia

Neurology, 2016
Hélène Pouclet-Courtemanche, T. Rouaud, S. Thobois, J. Nguyen, C. Brefel‐Courbon, I. Chéreau, E. Cuny, P. Derost, A. Eusebio, D. Guehl, C. Laurencin, P. Mertens, F. Ory-Magne, S. Raoul, J. Régis, M. Ulla, T. Witjas, P. Burbaud, O. Rascol, P. Damier   +19 more
semanticscholar   +1 more source

Attenuation of levodopa-induced dyskinesia by normalizing dopamine D3 receptor function

Nature Medicine, 2003
Holger Stark, Thomas Boraud, Pierre Sokoloff   +2 more
exaly  

Comparing the risk of tardive dyskinesia in older adults with first‐generation and second‐generation antipsychotics: a systematic review and meta‐analysis

International Journal of Geriatric Psychiatry, 2016
A. O'Brien
semanticscholar   +1 more source

Mutations in DNAH5 cause primary ciliary dyskinesia and randomization of left–right asymmetry

Nature Genetics, 2002
Richard Reinhardt, Hannah M Mitchison, Maggie Meeks   +2 more
exaly  

Pharmacogenetics of tardive dyskinesia: an updated review of the literature.

Pharmacogenomics (London), 2016
Rachel Lanning, C. Zai, D. Müller
semanticscholar   +1 more source

Loss of bidirectional striatal synaptic plasticity in L-DOPA–induced dyskinesia

Nature Neuroscience, 2003
Barbara Picconi, Diego Centonze, Paul Greengard   +2 more
exaly  

Tardive Dyskinesia

Annual Review of Medicine, 1975
openaire   +3 more sources

Drug-Induced Dyskinesia, Part 2: Treatment of Tardive Dyskinesia

Drugs, 2016
Dhanya Vijayakumar, J. Jankovic
semanticscholar   +1 more source

Pathophysiology of levodopa-induced dyskinesia: Potential for new therapies

Nature Reviews Neuroscience, 2001
Erwan Bezard, Jonathan M Brotchie
exaly  

Cell type-specific plasticity of striatal projection neurons in parkinsonism and L-DOPA-induced dyskinesia

Nature Communications, 2014
Tim Fieblinger, Cristina Alcacer, Joshua L Plotkin   +2 more
exaly